John A. Oates

46.6k total citations · 14 hit papers
343 papers, 33.9k citations indexed

About

John A. Oates is a scholar working on Pharmacology, Molecular Biology and Biochemistry. According to data from OpenAlex, John A. Oates has authored 343 papers receiving a total of 33.9k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Pharmacology, 74 papers in Molecular Biology and 74 papers in Biochemistry. Recurrent topics in John A. Oates's work include Inflammatory mediators and NSAID effects (96 papers), Eicosanoids and Hypertension Pharmacology (64 papers) and Pharmacogenetics and Drug Metabolism (35 papers). John A. Oates is often cited by papers focused on Inflammatory mediators and NSAID effects (96 papers), Eicosanoids and Hypertension Pharmacology (64 papers) and Pharmacogenetics and Drug Metabolism (35 papers). John A. Oates collaborates with scholars based in United States, Canada and Japan. John A. Oates's co-authors include Alastair J.J. Wood, L. Jackson Roberts, Alan Brash, Brian J. Sweetman, Barry D. Kahan, Jack Hirsh, David G. Shand, Jürgen C. Frölich, Albert Sjoerdsma and Garret A. FitzGerald and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

John A. Oates

339 papers receiving 31.3k citations

Hit Papers

2009 Focused Update Incor... 1970 2026 1988 2007 2009 1989 2009 1991 1988 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
    2009 2.9k citations Sharon A. Hunt, William T. Abraham et al. profile →
  2. Cyclosporine
    1989 1.1k citations John A. Oates, Alastair J.J. Wood et al. New England Journal of Medicine profile →
  3. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
    2009 1.1k citations Sharon A. Hunt, William T. Abraham et al. Journal of the American College of Cardiology profile →
  4. Heparin
    1991 646 citations John A. Oates, Alastair J.J. Wood et al. New England Journal of Medicine profile →
  5. HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
    1988 631 citations John A. Oates, Alastair J.J. Wood et al. New England Journal of Medicine profile →
  6. Nonsteroidal Antiinflammatory Drugs — Differences and Similarities
    1991 626 citations John A. Oates, Alastair J.J. Wood et al. New England Journal of Medicine profile →
  7. Therapeutic Uses of Botulinum Toxin
    1991 608 citations John A. Oates, Alastair J.J. Wood et al. New England Journal of Medicine profile →
  8. Effects of Caffeine on Plasma Renin Activity, Catecholamines and Blood Pressure
    1978 607 citations David G. Shand, John A. Oates et al. New England Journal of Medicine profile →
  9. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
    1983 540 citations John A. Oates, L. Jackson Roberts et al. profile →
  10. Antimicrobial Prophylaxis in Surgery
    1986 528 citations John A. Oates, Alastair J.J. Wood et al. New England Journal of Medicine profile →
  11. Manipulating the Immune System with Immune Globulin
    1992 497 citations John A. Oates, Alastair J.J. Wood et al. New England Journal of Medicine profile →
  12. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE.
    1982 482 citations John A. Oates, L. Jackson Roberts et al. profile →
  13. Plasma propranolol levels in adults With observations in four children
    1970 454 citations David G. Shand, John A. Oates et al. profile →
  14. Urinary prostaglandins. Identification and origin.
    1975 417 citations John A. Oates et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Oates United States 96 9.2k 7.1k 5.8k 5.5k 4.6k 343 33.9k
Carlo Patrono Italy 87 17.6k 1.9× 10.7k 1.5× 4.2k 0.7× 7.4k 1.3× 2.5k 0.5× 369 35.9k
R. Wayne Alexander United States 92 14.1k 1.5× 2.0k 0.3× 11.2k 1.9× 5.3k 1.0× 8.6k 1.8× 198 35.4k
Friedrich C. Luft Germany 112 16.9k 1.8× 3.8k 0.5× 12.8k 2.2× 6.8k 1.2× 8.8k 1.9× 1.1k 50.6k
Barry M. Brenner United States 91 13.0k 1.4× 2.2k 0.3× 7.8k 1.3× 3.9k 0.7× 5.2k 1.1× 296 39.7k
Pál Pacher United States 112 5.5k 0.6× 11.8k 1.7× 11.9k 2.0× 4.5k 0.8× 8.2k 1.8× 391 44.6k
Jason D. Morrow United States 113 2.6k 0.3× 7.9k 1.1× 12.7k 2.2× 3.2k 0.6× 8.1k 1.8× 404 42.4k
Ernesto L. Schiffrin Canada 101 18.9k 2.1× 2.3k 0.3× 9.2k 1.6× 5.5k 1.0× 11.1k 2.4× 567 39.0k
Rhian M. Touyz Canada 104 12.6k 1.4× 2.2k 0.3× 11.0k 1.9× 4.5k 0.8× 9.2k 2.0× 522 37.0k
John F. Keaney United States 92 8.8k 1.0× 1.2k 0.2× 6.3k 1.1× 4.1k 0.8× 9.0k 1.9× 254 31.1k
John R. Vane United Kingdom 113 12.3k 1.3× 24.7k 3.5× 13.2k 2.3× 6.9k 1.3× 18.4k 4.0× 468 63.3k

Countries citing papers authored by John A. Oates

Since Specialization
Citations

This map shows the geographic impact of John A. Oates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Oates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Oates more than expected).

Fields of papers citing papers by John A. Oates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Oates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Oates. The network helps show where John A. Oates may publish in the future.

Co-authorship network of co-authors of John A. Oates

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Oates. A scholar is included among the top collaborators of John A. Oates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Oates. John A. Oates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boutaud, Olivier, Taneem Amin, Hyun Seok Hwang, et al.. (2016). Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis. Cancer Prevention Research. 9(11). 855–865. 44 indexed citations
2.
Judd, Audra M., Kalyani Amarnath, Venkataraman Amarnath, et al.. (2015). Modification of platelet proteins by malondialdehyde: prevention by dicarbonyl scavengers. Journal of Lipid Research. 56(11). 2196–2205. 19 indexed citations
3.
Hunt, Sharon A., William T. Abraham, Marshall H. Chin, et al.. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. Journal of the American College of Cardiology. 53(15). e1–e90. 1065 indexed citations breakdown →
4.
Hebert, Patricia R., Christopher S. Coffey, Daniel W. Byrne, et al.. (2008). Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death. Journal of the American Society of Hypertension. 2(5). 355–365.e2. 9 indexed citations
5.
Boutaud, Olivier, Thomas J. Montine, Lei Chang, William L. Klein, & John A. Oates. (2006). PGH2‐derived levuglandin adducts increase the neurotoxicity of amyloid β1–42. Journal of Neurochemistry. 96(4). 917–923. 38 indexed citations
6.
Eikelboom, John W., Mark Feldman, Shamir R. Mehta, et al.. (2005). Aspirin resistance and its implications in clinical practice.. PubMed. 7(3). 76–76. 6 indexed citations
7.
Dworski, Ryszard, et al.. (2000). Prostaglandin E2 Decreases Allergen-stimulated Release of Prostaglandin D2 in Airways of Subjects with Asthma. American Journal of Respiratory and Critical Care Medicine. 162(2). 637–640. 79 indexed citations
8.
Dworski, Ryszard, et al.. (1999). Allergen-induced Synthesis of F2-Isoprostanes in Atopic Asthmatics: Evidence for Oxidant Stress. American Journal of Respiratory and Critical Care Medicine. 160(6). 1947–1951. 104 indexed citations
9.
Szczeklik, Andrzej, Ryszard Dworski, Lucyna Mastalerz, et al.. (1998). Salmeterol Prevents Aspirin-induced Attacks of Asthma and Interferes with Eicosanoid Metabolism. American Journal of Respiratory and Critical Care Medicine. 158(4). 1168–1172. 30 indexed citations
10.
Dworski, Ryszard, Colin Funk, John A. Oates, & James R. Sheller. (1997). Prednisone Increases PGH-Synthase 2 in Atopic Humans In Vivo. American Journal of Respiratory and Critical Care Medicine. 155(1). 351–357. 13 indexed citations
11.
Morrow, Jason D., Cynthia Guzzo, Gerald S. Lazarus, John A. Oates, & L. Jackson Roberts. (1995). Improved Diagnosis of Mastocytosis by Measurement of the Major Urinary Metabolite of Prostaglandin D2. Journal of Investigative Dermatology. 104(6). 937–940. 43 indexed citations
12.
Sładek, Krzysztof, Ryszard Dworski, Jerzy Soja, et al.. (1994). Eicosanoids in Bronchoalveolar Lavage Fluid of Aspirin-Intolerant Patients with Asthma After Aspirin Challenge. American Journal of Respiratory and Critical Care Medicine. 149(4). 940–946. 127 indexed citations
13.
Dworski, Ryszard, Garrett Fitzgerald, John A. Oates, & James R. Sheller. (1994). Effect of Oral Prednisone on Airway Inflammatory Mediators in Atopic Asthma. American Journal of Respiratory and Critical Care Medicine. 149(4). 953–959. 227 indexed citations
14.
Oates, John A., et al.. (1991). Therapeutic Uses of Botulinum Toxin. New England Journal of Medicine. 324(17). 1186–1194. 608 indexed citations breakdown →
15.
Oates, John A., et al.. (1988). HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia. New England Journal of Medicine. 319(1). 24–33. 631 indexed citations breakdown →
16.
Ueda, Natsuo, Chieko Yokoyama, Shozo Yamamoto, et al.. (1987). Lipoxin synthesis by arachidonate 12-lipoxygenase purified from porcine leukocytes. Biochemical and Biophysical Research Communications. 149(3). 1063–1069. 24 indexed citations
17.
Duff, Henry J., Dan M. Roden, Alastair J.J. Wood, et al.. (1983). Electrophysiologic actions of high plasma concentrations of propranolol in human subjects. Journal of the American College of Cardiology. 2(6). 1134–1140. 42 indexed citations
18.
Duff, Henry J., et al.. (1982). Comparison of the effects of placebo and encainide on programmed electrical stimulation and ventricular arrhythmia frequency. The American Journal of Cardiology. 50(2). 305–312. 21 indexed citations
19.
20.
Oates, John A., et al.. (1971). DISTRIBUTION OF GUANIDINIUM ANTIHYPERTENSIVES—MECHANISM OF THEIR SELECTIVE ACTION*. Annals of the New York Academy of Sciences. 179(1). 302–308. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlo Patrono Breakdown of academic impact, for papers by R. Wayne Alexander Breakdown of academic impact, for papers by Friedrich C. Luft Breakdown of academic impact, for papers by Barry M. Brenner Breakdown of academic impact, for papers by Pál Pacher Breakdown of academic impact, for papers by Jason D. Morrow Breakdown of academic impact, for papers by Ernesto L. Schiffrin Breakdown of academic impact, for papers by Rhian M. Touyz Breakdown of academic impact, for papers by John F. Keaney Breakdown of academic impact, for papers by John R. Vane
Rankless by CCL
2026